COMMUNIQUÉS West-GlobeNewswire

NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
17/04/2024
Conference call and webcast scheduled for Thursday, April 25, 2024, at 8:00 am EDT / 2:00 pm. CEST PARIS and CAMBRIDGE, Mass., April 17, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ [...]
NANOBIOTIX publiera ses résultats financiers et opérationnels de l'exercice 2023 le 24 avril 2024
17/04/2024
Conférence téléphonique et diffusion en direct sur Internet le jeudi 25 avril 2024 à 14 h 00 CEST / 8 h 00 EDT PARIS et CAMBRIDGE, Mass., 17 avr. 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – [...]
Inari Medical to Announce First Quarter 2024 Financial Results
17/04/2024
IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
17/04/2024
SAN FRANCISCO, April 17, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of [...]
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
17/04/2024
MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report [...]
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
17/04/2024
- Dr. Gill brings extensive leadership experience in transformative biotechnology platforms and drug development - HUNTSVILLE, AL, April 17, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (NYSE American: SER), a [...]
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
17/04/2024
SEATTLE, April 17, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
17/04/2024
DENVER, April 17, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a commercial-stage medical device company developing proprietary solutions to reduce the [...]
ClearPoint Neuro félicite son partenaire AviadoBio pour son premier patient traité dans le cadre de son essai clinique ASPIRE-FTD évaluant l’AVB-101 dans la démence fronto-temporale avec mutations du gène GRN
17/04/2024
Les centres ASPIRE-FTD dans l’UE et aux États-Unis utiliseront la navigation ClearPoint® avec la canule SmartFlow® pour l’administration de thérapie génique intrathalamique SOLANA BEACH, Californie, 17 avr. 2024 (GLOBE [...]
Hospice Choices: VITAS® Healthcare Opens in Alabama, Expands in Florida Panhandle
17/04/2024
A Media Snippet accompanying this announcement is available by clicking on this link . TALLAHASSEE, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- Hospice patients and their families in the Florida Panhandle and areas in [...]
River Oaks Treatment Center is Setting the Standard for Clinical Excellence in Florida with Four Board-Certified Addiction Medicine Physicians
17/04/2024
RIVERVIEW, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- River Oaks Treatment Center is proud to announce that it has two additional board-certified addiction medicine physicians on its staff. Dr. Michael Murphy and Dr. [...]
Ipsen publishes its 2023 Universal Registration Document
17/04/2024
Ipsen publishes its 2023 Universal Registration Document PARIS, FRANCE, 17 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty biopharmaceutical group, announces that its 2023 Universal Registration [...]
Ipsen publie son Document d’enregistrement universel 2023
17/04/2024
Ipsen publie son Document d’enregistrement universel 2023 PARIS, FRANCE, 17 avril 2024 - Ipsen (Euronext : IPN ; ADR : IPSEY) groupe biopharmaceutique mondial de spécialité annonce que son Document d’enregistrement [...]
AAMI Releases Guidance on Dilator, Ultrasound DeSterilization
17/04/2024
Arlington, Virginia, April 17, 2024 (GLOBE NEWSWIRE) -- A new guidance document on the sterile processing of dilators and ultrasound probes in healthcare facilities has been published by the Association for the [...]
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects.
17/04/2024
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) -- The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most common form of [...]
Change in Leadership at AFB’s Journal of Visual Impairment & Blindness as Longtime Editor in Chief Sandra Lewis Steps Down, Robert Wall Emerson of Western Michigan University to Fill the Role
17/04/2024
WASHINGTON, April 17, 2024 (GLOBE NEWSWIRE) -- After nine years at the helm of AFB’s Journal of Visual Impairment & Blindness (JVIB) , Sandra Lewis, Ed.D., Florida State University (retired), has expressed her [...]
Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
17/04/2024
The organizations will host an event with Canada’s leading providers, employers, and fertility advocates to show support for the millions in need of family building care NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- [...]
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
17/04/2024
Boston (April 17, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that it [...]
G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
17/04/2024
RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, will host a webcast and conference call to provide a financial and corporate [...]

Pages